Medium- or macro-cyclic benzyl-substituted heterocycle derivatives and related uses

TW202626665APending Publication Date: 2026-07-01CENTESSA PHARMACEUTICALS (UK) LIMITED
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
TW115111609
Authority / Receiving Office
TW · TW
Patent Type
Applications
Current Assignee / Owner
Priority Date
2023-01-17
Filing Date
2023-03-01
Publication Date
2026-07-01
Patent Text Reader

Abstract

The present disclosure relates to compounds of Formula (I’): , and to their prodrugs, pharmaceutically acceptable salts, pharmaceutical compositions, methods of use, and methods for their preparation. The compounds disclosed herein are useful for modulating orexin-2 receptor activity and may be used in the treatment of disorders in which orexin-2 receptor activity is implicated, such as narcolepsy, a hypersomnia disorder, a neurodegenerative disorder, a symptom of a rare genetic disorder, a mental health disorder, a metabolic syndrome, osteoporosis, cardiac failure, coma, or facilitating emergence from anaesthesia.
Need to check novelty before this filing date? Find Prior Art